Israeli study may open door to preventing relapse of certain types of lung cancer

Researchers at Weizmann Institute studying mice identify genetic mutation as potential biomarker for successful treatment with existing drug

Related Keywords

Rome ,Lazio ,Italy ,Israel ,Israeli ,Yosef Yarden ,Ilaria Marrocco ,Michael Sela ,Ilaria Marrocco Courtesy Of The Weizmann Institute ,Department Of Life Sciences ,Courtesy Of The Weizmann Institute ,Weizmann Institute ,Public Health ,Epidermal Growth Factor Receptor ,Cell Reports Medicine ,Daily Editionby ,Life Sciences ,Cattolica Del Sacro Cuore ,